Mark C. Zobeck, MD, MPH
Department or Service
- Texas Medical Center
- Developmental therapeutics
- Epidemiology (Cancer and Hematology)
Instructor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
|Baylor College of Medicine||fellowship||Pediatric Hematology-Oncology||2020|
|Texas Children's Hospital||residency||Pediatrics||2017|
|Texas Tech Health Sciences Center El Paso Paul Foster School of Medicine||medical school||Doctor of Medicine||2014|
|University of Texas at Houston School of Public Health||masters||Masters of Public Health||2014|
|Texas A&M University||bachelors||Bachelor of the Arts, Chemistry||2010|
Dr. Mark Zobeck completed his pediatric hematology/oncology fellowship training in 2020. He is passionate about caring for children with cancer and blood disorders. His goal is to care for the entire family, not only by treating the patient's illness, but also by walking alongside families as a supportive human presence through the difficulties caused by a disease.
Dr. Zobeck graduated with honors from medical school and completed general pediatrics residency training at Texas Children's Hospital, one of the top programs in the country. He pursues excellence in his clinical practice and believes the best patient care starts with communication and human connection.
Dr. Zobeck has a special interest in global pediatric hematology-oncology. The vast majority of children with blood disorders and cancer live in resource-limited countries, where death and other disease complications are extremely common. Dr. Zobeck believes that all child, regardless of where they live, deserve the best treatment possible for their disease. To address this problem, he researches how to overcome the unique difficulties of providing high-quality care in these settings. His current focus is in Sub-Saharan Africa, where he is working to reduce the rate of patients who abandon treatment after they are diagnosed with cancer.
American Board of Pediatrics
|American Academy of Pediatrics (AAP)||Member|
|American Society of Clinical Oncology (ASCO)||Member|
|American Society of Hematology (ASH)||Member|
|American Society of Pediatric Hematology/Oncology (ASPHO)||Member|
|Children's Oncology Group (COG)||Member|
|International Society of Paediatric Oncology (SIOP)||Member|
Dr. Zobeck also does research in the area of pharmacogenomics. He applies insights from advanced genetic testing to help individualize medication dosing to avoid serious adverse effects. Specifically, he is looking at the prevalence of certain genes that are known be associated with medication side effects in the population of patients at Texas Children's Hospital. He correlates these genes to clinical and financial outcomes for the patients, to better understanding which patients are at highest risk for medication-related complicaitons. His research will allow doctors to better tailor treatment to meet the unique needs of individual patients.
2020 Young Investigator Award, International Society of Paediatric Oncology (SIOP)